FiltersReset Filters

With box warnings

Without box warnings

Branded

Generic

4 results

atomoxetine
(Atomoxetine)
Aurobindo Pharma Limited
Usage: Atomoxetine capsules are indicated for the treatment of Attention-Deficit/Hyperactivity Disorder (ADHD) in pediatric patients aged 6-18 and adults. They are part of a comprehensive treatment program that may include psychological and educational measures, and are not intended for patients with ADHD symptoms secondary to environmental factors or other psychiatric conditions.
atomoxetine
(Atomoxetine)
Rising Pharma Holdings, Inc.
Usage: Atomoxetine capsules are indicated for the treatment of Attention-Deficit/Hyperactivity Disorder (ADHD) in pediatric patients (ages 6-18) and adults. It is part of a comprehensive treatment program, which may include other psychological, educational, and social interventions. It is not intended for symptoms due to environmental factors or primary psychiatric disorders.
atomoxetine
(atomoxetine)
Glenmark Pharmaceuticals Inc., USA
Usage: Atomoxetine capsules are indicated for the treatment of Attention-Deficit/Hyperactivity Disorder (ADHD) in pediatric patients (ages 6-18) and adults. It is part of a comprehensive treatment program which may include psychological and educational measures, and is not intended for patients with symptoms due to environmental factors or other psychiatric disorders.
qelbree
(viloxazine hydrochloride)
Supernus Pharmaceuticals, Inc
Usage: Qelbree is indicated for the treatment of Attention-Deficit Hyperactivity Disorder (ADHD) in individuals aged 6 years and older, including adults.

Norepinephrine Reuptake Inhibitor class drugs

atomoxetine

atomoxetine

atomoxetine

qelbree